Compare BXMT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BXMT | TXG |
|---|---|---|
| Founded | 1966 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 4.4B |
| IPO Year | 1998 | 2019 |
| Metric | BXMT | TXG |
|---|---|---|
| Price | $17.77 | $34.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 15 |
| Target Price | ★ $21.38 | $20.25 |
| AVG Volume (30 Days) | 1.2M | ★ 3.3M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 9.85% | N/A |
| EPS Growth | ★ 154.70 | 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $17.67 | $11.17 |
| 52 Week High | $20.67 | $36.59 |
| Indicator | BXMT | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 40.93 | 64.33 |
| Support Level | N/A | $16.11 |
| Resistance Level | $18.84 | $35.65 |
| Average True Range (ATR) | 0.34 | 2.49 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 0.58 | 74.48 |
Blackstone Mortgage Trust Inc is an externally managed real estate finance company that originates, acquires, and manages senior loans and other debt or credit-oriented investments collateralized by or relating to commercial real estate in North America, Europe, and Australia. Its portfolio is composed of senior loans secured by high-quality, institutional assets located in main markets, and sponsored by experienced, well-capitalized real estate investment owners and operators. The group finances its investments in a variety of ways, including borrowing under secured credit facilities, issuing collateralized loan obligations, or CLOs, other securitization transactions, syndicating senior loans and/or participations, and other forms of asset-level financing.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).